8 active trials 4 recruiting 1 Phase 3 5 disease areas 1 changes in 30 days
| Phase 2 | 5 | |
| Phase 2/3 | 1 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 2/3 | ||||
| NCT01924819 | Trial of Preoperative Therapy for Gastric and Esophagogastric Junction Adenocarcinoma | Gastric Cancer | Active, Not Recruiting | 2025-03-04 |
| Phase 2 | ||||
| NCT06345079 | Cessation of Somatostatin Analogues After PRRT in Mid, Hind-Gut and Pancreatic… | Neuroendocrine Tumors | Recruiting | 2026-09-10 |
| NCT06290505 | A Trial of Palliative Chemotherapy, Radiation and Immune Treatment for Oesophageal… | Esophageal Cancer | Recruiting | 2026-05-08 |
| NCT06441747 | Phase II Study of the Combination of Durvalumab (MEDI4736) (PDL1 Inhibitor) and Olaparib… | Cholangiocarcinoma | Recruiting | 2026-05-06 |
| NCT05694936 | Combining Sodium Valproate With Standard-of-care EGFR (Epidermal Growth Factor Receptor)… | Metastatic Colorectal Cancer | Active, Not Recruiting | 2026-05-08 |
| NCT06094140 | NEO-adjuvant Chemo-immunotherapy in Pancreatic Cancer | Pancreatic Cancer | Active, Not Recruiting | 2026-05-06 |
| Not applicable | ||||
| NCT06604533 | Magnetic Resonance Imaging (MRI) Guided Stereotactic Adaptive Radiotherapy for Targeting… | Abdominal Cancer | Recruiting | 2026-05-08 |
| NCT05862051 | RESOLUTE Trial Aims to Investigate the Value of Adding Local Ablative Treatment to… | Colorectal Cancer | Active, Not Recruiting | 2026-05-08 |
Colorectal Cancer (2) · Cholangiocarcinoma (1) · Esophageal Cancer (1) · Gastric Cancer (1) · Pancreatic Cancer (1)